Clinical Trial Update: Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost [Phase 2]

View source ↗

Summary

This Phase 2 trial update assesses the safety and intraocular pressure-lowering efficacy of low-dose Travoprost in patients with open-angle glaucoma and ocular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travoprost (Travoprost (isomer-free))

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED